16-1787942-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012225.4(NUBP2):c.491C>T(p.Ala164Val) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000673 in 1,604,570 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012225.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NUBP2 | NM_012225.4 | c.491C>T | p.Ala164Val | missense_variant, splice_region_variant | 5/7 | ENST00000262302.14 | NP_036357.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NUBP2 | ENST00000262302.14 | c.491C>T | p.Ala164Val | missense_variant, splice_region_variant | 5/7 | 1 | NM_012225.4 | ENSP00000262302 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152178Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000115 AC: 28AN: 242824Hom.: 0 AF XY: 0.0000908 AC XY: 12AN XY: 132170
GnomAD4 exome AF: 0.0000441 AC: 64AN: 1452274Hom.: 0 Cov.: 36 AF XY: 0.0000443 AC XY: 32AN XY: 722090
GnomAD4 genome AF: 0.000289 AC: 44AN: 152296Hom.: 0 Cov.: 34 AF XY: 0.000255 AC XY: 19AN XY: 74460
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 09, 2022 | The c.491C>T (p.A164V) alteration is located in exon 5 (coding exon 5) of the NUBP2 gene. This alteration results from a C to T substitution at nucleotide position 491, causing the alanine (A) at amino acid position 164 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at